Elutia Inc. (ELUT)
NASDAQ: ELUT · IEX Real-Time Price · USD
3.310
+0.090 (2.80%)
At close: May 17, 2024, 4:00 PM
3.110
-0.200 (-6.04%)
After-hours: May 17, 2024, 6:45 PM EDT
Elutia Market Cap
Elutia has a market cap or net worth of $92.79 million as of May 17, 2024. Its market cap has increased by 151.46% in one year.
Market Cap
92.79M
Enterprise Value
116.03M
1-Year Change
151.46%
Ranking
Category
Stock Price
$3.31
Market Cap Chart
Since the IPO on October 8, 2020, Elutia's market cap has decreased from $173.84M to $92.79M, a decrease of -46.62%. That is a compound annual growth rate of -15.97%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 80.60M | 2.81% |
May 16, 2024 | 78.40M | -1.88% |
May 15, 2024 | 79.90M | -1.72% |
May 14, 2024 | 81.30M | -2.40% |
May 13, 2024 | 83.30M | 4.26% |
May 10, 2024 | 79.90M | 17.50% |
May 9, 2024 | 68.00M | -4.09% |
May 8, 2024 | 70.90M | 0.71% |
May 7, 2024 | 70.40M | 1.00% |
May 6, 2024 | 69.70M | -1.97% |
May 3, 2024 | 71.10M | 4.56% |
May 2, 2024 | 68.00M | -1.73% |
May 1, 2024 | 69.20M | 2.98% |
Apr 30, 2024 | 67.20M | -5.49% |
Apr 29, 2024 | 71.10M | 5.33% |
Apr 26, 2024 | 67.50M | -3.85% |
Apr 25, 2024 | 70.20M | - |
Apr 24, 2024 | 70.20M | 0.86% |
Apr 23, 2024 | 69.60M | -1.83% |
Apr 22, 2024 | 70.90M | 0.42% |
Apr 19, 2024 | 70.60M | -4.59% |
Apr 18, 2024 | 74.00M | 0.27% |
Apr 17, 2024 | 73.80M | 6.19% |
Apr 16, 2024 | 69.50M | -1.84% |
Apr 15, 2024 | 70.80M | -2.48% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
InflaRx | 94.21M |
Oramed Pharmaceuticals | 93.85M |
Xtant Medical Holdings | 93.77M |
Eton Pharmaceuticals | 93.13M |
Milestone Pharmaceuticals | 92.94M |
Barinthus Biotherapeutics | 91.54M |
IO Biotech | 90.92M |
Anixa Biosciences | 90.60M |